EKSO Q3 2021 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$30M

Q3 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$3M+5.2% YoY

Gross Profit

$2M59.3% margin

Operating Income

-$3M-91.5% margin

Net Income

-$2M-64.2% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

+37.9%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$3M

Stock-Based Comp.

$697,000

Balance Sheet

Total Assets

$51M

Total Liabilities

$12M

Stockholders' Equity

$39M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+5.2%
Gross Profit	$2M	$2M	-0.3%
Operating Income	-$3M	-$2M	-15.2%
Net Income	-$2M	$2M	-179.9%

Revenue Segments

EksoHealth

$3M89%

EksoWorks

$333,00011%

Geographic Segments

Americas

$2M32%

UNITED STATES

$2M31%

EMEA

$828,00015%

EMEA, Other

$515,0009%

Asia Pacific

$419,0007%

GERMANY

$313,0006%

Americas, Other

$25,0000%